ATE336T1 - STABILIZED PLATELET FACTOR 4 IMMUNASSAY CALIBRATION SOLUTIONS AND RADIOIMMUNASSAY METHODS. - Google Patents

STABILIZED PLATELET FACTOR 4 IMMUNASSAY CALIBRATION SOLUTIONS AND RADIOIMMUNASSAY METHODS.

Info

Publication number
ATE336T1
ATE336T1 AT79300880T AT79300880T ATE336T1 AT E336 T1 ATE336 T1 AT E336T1 AT 79300880 T AT79300880 T AT 79300880T AT 79300880 T AT79300880 T AT 79300880T AT E336 T1 ATE336 T1 AT E336T1
Authority
AT
Austria
Prior art keywords
platelet factor
immunassay
radioimmunassay
methods
stabilized
Prior art date
Application number
AT79300880T
Other languages
German (de)
Inventor
Erwin F. Jr. Workman
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25446555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE336(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ATE336T1 publication Critical patent/ATE336T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

The present invention encompasses a stabilized platelet factor4 immunoassay standard comprising an aqueous solution containing 10 to 100ng/ml of platelet factor 4, carrier protein, and an effective stabilizing amount of heparin, as well as <sup>125</sup>llabeled platelet factor 4 reagent stabilized in the same manner. These reagents are useful for testing blood plasma for activation of the coagulation system.
AT79300880T 1978-07-05 1979-05-18 STABILIZED PLATELET FACTOR 4 IMMUNASSAY CALIBRATION SOLUTIONS AND RADIOIMMUNASSAY METHODS. ATE336T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/922,135 US4195072A (en) 1978-07-05 1978-07-05 Stabilized platelet factor 4 immunoassay standards
EP79300880A EP0007163B1 (en) 1978-07-05 1979-05-18 Stabilized platelet factor 4 immunoassay standards and radio-immunoassay method

Publications (1)

Publication Number Publication Date
ATE336T1 true ATE336T1 (en) 1981-11-15

Family

ID=25446555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79300880T ATE336T1 (en) 1978-07-05 1979-05-18 STABILIZED PLATELET FACTOR 4 IMMUNASSAY CALIBRATION SOLUTIONS AND RADIOIMMUNASSAY METHODS.

Country Status (9)

Country Link
US (1) US4195072A (en)
EP (1) EP0007163B1 (en)
JP (1) JPS5928865B2 (en)
AT (1) ATE336T1 (en)
AU (1) AU525406B2 (en)
CA (1) CA1116078A (en)
DE (1) DE2961056D1 (en)
ES (1) ES482215A1 (en)
ZA (1) ZA792524B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903701C2 (en) * 1979-01-31 1980-10-16 Boehringer Mannheim Gmbh, 6800 Mannheim Control reagent for the determination of the heparin activity
US4311482A (en) * 1979-10-09 1982-01-19 Abbott Laboratories Method and apparatus for collecting blood samples
DE3019612A1 (en) * 1980-05-22 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim STABILIZED THROMBINE PREPARATION
FR2585836B1 (en) * 1985-08-02 1987-11-27 Commissariat Energie Atomique HOMOGENEOUS METHOD FOR LUMINESCENCE DETECTION AND / OR DETERMINATION OF AN ANALYTE IN A MEDIUM CONTAINING IT
US5166078A (en) * 1986-08-19 1992-11-24 Idexx Laboratories, Inc. Hapten-macromolecule conjugates useful in hapten assays
ES2078264T3 (en) * 1989-06-02 1995-12-16 Abbott Lab STANDARD REAGENTS FOR THE QUANTIFICATION OF HIV P24.
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960492A (en) * 1974-05-31 1976-06-01 Nuclear Diagnostics, Inc. Method for determining an index of binding protein content of blood
US4086218A (en) * 1975-04-11 1978-04-25 Edward Shanbrom, Inc. Method of preserving blood plasma II
US3985618A (en) * 1975-05-02 1976-10-12 Irving Innerfield Method for detection of thrombosis and prethrombosis
DE2601372C3 (en) * 1976-01-15 1980-03-27 Behringwerke Ag, 3550 Marburg Method for the determination of antithrombin III
US4097238A (en) * 1977-06-03 1978-06-27 Ashley Sheldon J Method of analyzing blood plasma clotting

Also Published As

Publication number Publication date
ES482215A1 (en) 1980-08-16
DE2961056D1 (en) 1981-12-24
EP0007163A1 (en) 1980-01-23
CA1116078A (en) 1982-01-12
EP0007163B1 (en) 1981-10-21
JPS5928865B2 (en) 1984-07-16
AU4738979A (en) 1980-01-31
ZA792524B (en) 1980-06-25
AU525406B2 (en) 1982-11-04
US4195072A (en) 1980-03-25
JPS5510598A (en) 1980-01-25

Similar Documents

Publication Publication Date Title
ATE93323T1 (en) LATEX AGGLUTINATION IMMUNOTEST IN THE PRESENCE OF HAEMOGLOBIN.
DE3767755D1 (en) MICROBIOLOGICAL DESULFURATION OF GASES.
IT1115552B (en) PROCEDURE FOR THE SELECTIVE ELIMINATION OF LIPOPROTEINS FROM PLASMA OR BLOOD SERUM
LV10538A (en) Influence of immunologically binding agent on biological fluid and diagnostic agent
SE8602404L (en) NEW FORMULATION
DE68901098D1 (en) COMPOSITION OF ANTICOAGULANTIA.
FI843616A0 (en) ANALYTICAL FORM OF BIOLOGICAL EXAMINATION AV ETT VEGETABILISKT RAOMATERIAL.
AU525406B2 (en) Stabilized platelet factor 4 immunoassay standards
FI865022A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV REAGENSPAPPER FOER IMMUNOLOGISKA ANALYSER.
NO874783D0 (en) PROCEDURE FOR QUANTITY DETERMINATION OF STABLE GLYCOSYLED HEMOGLOBIN.
Iwata et al. Isolation of Albumin from Human Serum by Means of Trichloroacetic Acid and Ethanol: A Comparison of Methods
GB1274089A (en) Blood platelet stabilising reagent
ES8302099A1 (en) &#34;PROCEDURE FOR THE OPTICAL DETERMINATION OF THE BLOOD COAGULATION BEHAVIOR&#34;.
ES435761A1 (en) Radioisotopic assay and binder therefor
Fantl Thiol groups of blood platelets in relation to clot retraction
Narayan et al. A modified disc electrophoretic method for animal blood serum proteins
FR2665769B1 (en) DETERMINATION OF THROMBOPENIA ESPECIALLY INDUCED BY HEPARIN BY MEANS OF THE PLATELET FACTOR 4.
BE848697A (en) REAGENT IN STABLE SOLUTION FOR THE DETECTION OF OXIDASE,
FI904773A7 (en) Stabilizing reagent for membrane immunoassay
RU94012324A (en) Test system for detecting proteins in urine
KR920702415A (en) Stabilization immobilized enzyme
KR850700158A (en) Methods for Detecting Malignant Proliferation
ES8604691A1 (en) IMPROVEMENTS IN THE METHODS TO DETERMINE THE ACTIVITY OF CATEPSIN B IN THE PRESENCE OF OTHER PROTEOLYTIC ENZYMES
SU518679A1 (en) Method of histochemical detection of liver tissue red blood cell damage
ATE16809T1 (en) USE OF AN AGENT DERIVED FROM BLOOD SERUM TO STABILIZE PROSTAGLANDINS.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee